Article
A phase Ib study of pre-operative, locoregional IRX-2 cytokine immunotherapy to prime immune responses in patients with early stage breast cancer.
Clinical Cancer Research
(2019)
Disciplines
Publication Date
January 1, 2019
DOI
10.1158/1078-0432.CCR-19-1119
Citation Information
David B. Page, Joanna Pucilowska, Katherine G. Sanchez, Alison K Conlin, et al.. "A phase Ib study of pre-operative, locoregional IRX-2 cytokine immunotherapy to prime immune responses in patients with early stage breast cancer." Clinical Cancer Research (2019) Available at: http://works.bepress.com/walter-urba/291/